S_nary Children (0-14 years) with malignant brain and central nervous system (CNS) tumours (ICD9 191 and 192) were listed from the Scottish Cancer Registration Scheme for the years 1975-90. These cases formed the basis for validation and verification procedures aimed at providing a complete and accurate data set for epidemiological analyses. A variety of data sources were cross-checked to optimise ascertainment, and resulting from this 5.7% of validated cases were found on the cancer registry with diagnostic codes outside the ICD-9 range [191][192]. A further 8.4% were newly registered cases. Analyses were conducted on the validated data set showing a significant temporal increase in incidence rates over the 16 year study period with an average annual percentage change of + 2.6%. Large-scale geographical heterogeneity was also found, with a particularly high incidence in the Fife and Lothian areas and a low incidence in Grampian. Examination of associations with socioeconomic status, using the Carstairs deprivation index, revealed a rising trend in incidence strongly linked to areas with increasing levels of affluence. Our results suggest that for studies of childhood CNS tumours validation of cancer registry data is necessary and large-scale geographical variation and socioeconomic factors should be taken into account in any investigation of distribution in small geographical areas.
Recent technological advances in a range of diagnostic techniques have made the identification of tumours in the brain and central nervous system potentially more complete and accurate. However, temporal trends in the incidence of brain tumours are sparsely documented for children and young people, and international variation shows inconsistent trends (Davis et al., 1990 , Mao et al., 1991 . Suggested increases in incidence must be interpreted in relation to the impact of improved diagnostic techniques on the ascertainment of cases.
As a preliminary to a geographical study investigating the incidence of childhood cancer near nuclear facilities in Scotland, a validation exercise was initiated to provide an optimal data set in terms of completeness and accuracy. This involved cross-checking of alternative sources of ascertainment, validation of diagnosis and verification of case details. As part of this exercise the incidence and pathology of central nervous system (CNS) tumours in children in Scotland between 1975 and have been reviewed.
The main source of data for the study was the Scottish National Cancer Registration Scheme (SMR6). The two aims of this paper are to assess the completeness and accuracy of the original cancer registration data for childhood CNS tumours and, for the validated data set, to describe the incidence and broad geographical distribution in Scotland.
Data and methods

Data
A listing of all registrations of malignant CNS tumours in children aged 0-14 diagnosed in Scotland in 1975-90 was obtained from the Scottish National Cancer Registration Scheme. This included information on the diagnosis [tumour site and morphology coded to ICD-9 (WHO, 1977) and ICD-O (WHO, 1976 ) respectively] and case details such as the child's name, data of birth, post code of residence and hospital of treatment. In order to assess the completeness of ascertainment of the registry, computerised data linkage procedures were undertaken to compare the cancer registration case listing with the Scottish Morbidity Record for Inpatients (SMR1) and the UK National Registry of Childhood Tumours (Draper et al., 1988) . The linkage procedure matched data files on surname, initial, date of birth and post code sector. Exact matches were disregarded and mismatches examiined manually to establish the presence of potential new cases. The linkage resulted in a number of apparently unregistered cases which were added to the study data set.
For each cancer registration and potential new case a form was created showing initial diagnosis and case details and was passed to the collaborating pathologist (J.W.I.). The form was structured in order to permit the pathologists to indicate whether or not a particular item of cancer registration information could be verified and to record any amendments. During the course of searching hospital and pathology records the participating pathologists identified further potential cases. These were included in the study and submitted for formal review.
Pathologists were asked to record if slides had been available for the case review and to submit written diagnoses which were coded to ICD-9, ICD-O, ICD-10 (WHO, 1992) and ICD-02 . For the purposes of the epidemiological review, cases were also classified according to the Childhood Cancer Research Group (CCRG) modification (C.A. Stiller, personal communication) of the Birch and Marsden (1987) classification. Age-specific population estimates for health board areas and Scotland were abstracted from annual reports of the Registrar General Scotland (Registrar General Scotland, 1975-90) .
Statistical methods
Trends in incidence were examined by calculating age standardised rates, using the direct method (Boyle et al., 1991) and the world standard population (Muir et al., 1987) . Incidence rates throughout are expressed per million years of childhood (0-14 years) population. Average annual percentage changes in incidence were estimated by fitting regression lines to the logarithms of the age-standan'sed rates for the years 1975-90. Standarised registration ratios (SRRs) with 95% confidence intervals (Breslow & Day, 1987) were used to compare incidence in the health board areas of Scotland.
Carstairs deprivation scores of post code sectors based on socioeconomic variables from the 1981 census (Carstairs & Morris, 1991) Table I ). In five cases, no confirmatory information could be found and these, along with the eight described above, were excluded from the case review. The current standard coding schemes for cancer registration in the UK are ICD-9 for anatomical site and ICD-O for morphology. In epidemiological studies of childhood cancer it is common practice to use a specialised classification scheme incorporating both site and morphology (Birch & Marsden, 1987 1977 1979 1981 1983 1985 1987 1989 1976 1978 1980 1982 1984 1986 1988 1990 Year of diagnosis
Figue 1 World age-standardised incidence rates (per 1,000,000 population) of CNS and miscellaneous intracranial and intraspinal neoplasms by year of diagnosis for children 0-14 years, Scotland. 1975 -90. linear trend was observed (P = 0.005). (Glass et al., 1987) . A recent study in The Netherlands also showed a higher 6% error rate for registration of primary site (Schouten et al., 1993 Figwe 2 Numbers of cases (n). standardised registration ratios (SRRs) of all CNS neoplasms for health board (HB) of residence for children 0-14 years, Scotland, 1975-90. of cases points to inadequacies of the registration system and methods of case finding. This deficiency is currently being addresed, and use of computrised data from a vanety of sources, including pathology departments, will assist in the future. The fact that the reviewing pathologists were the primary source of our additional cases appears to support this. Overall, the errors we have documented are substantial enough to influence the results of small-area geographical studies and underline the importance of validating data when such work is contemplated. Descriptive epidemiology of childhood brain and CNS tumours, in common with all other childhood cancers, is based on a morphologically orientated classification scheme (Birch & Marsden, 1987) , and statistics prepared on cancer registry data, and therefore coded only by site, may differ. Fgwe 3 World age-&tandardised rates (per 1,000,000 population) for CNS and miscellaneous intracranial and intraspinal neoplasms by deprivation category for children 0-14 years, Scotland, 1975-90. rare groups of tumours which may be aetiologically distinct but have to be subsumed into larger groups for descriptive analyses. The potential for trends in incidence of rare tumours to be masked by results from larger subgroups is always present. The scheme for classifying childhood brain tumours incorporates five subgroups, and inevitably specific unusual tumours are too few in numbers to be examined separately.
The (Lannering et al., 1990) ; Finland, 31.2 per million; and Denmark, 30.9 per million (Parkin et al., 1988a) . These are at least 50% higher than observed rates in Hungary (18.4 per million) (Parkin et al., 1988a) . Incidence in the north of England for an earlier time period gives a crude intermediate rate of 25.7 per million (Craft et al., 1987) . The relative frequency of the diagnostic subgroups reflects the pattern of other population-based studies (Parkin et al., 1988a , Kallio et al., 1991 . The diffculties associated with the ascertainment of brain tumours and the fact that analysis of validated data gives rise to increased rates, as shown by our and other studies (Lannering et al., 1990) , suggests that published incidence figures based on cancer registration may be conservative. Sex ratios for the two most common subgroups of tumours, astrocytoma and medulloblastoma, show a female and a male excess respectively. For medulloblastomas this is consistent with international data (Parkin et al., 1988b) , but the finding for astrocytomas is unusual compared with other countries where sex ratios are generally close to unity. In the Scottish data the effect is most marked in the 1-9 year age group, however no explanation is immediately apparent for these observations. Temporal trends in incidence for childhood brain tumours have received little attention in the literature, which makes comparison of the Scottish finding of a significant increase difficult to set in the context of other countries. In this group of tumours, changes in diagnostic practice over time have been substantial, and an increase in numbers could be explained by improved availability of biopsy material for histological diagnosis. The reasons for suggesting the rise is real rather than artefactual are 2-fold. Firstly, the proportion of 'other and unspecified tumours' has not decreased to the same extent over the time period (1975, 15.4%; 1990, 8.1%) and neither has the proportion of histologically verified tumours changed (1975, 84.6%; 1990, 91.9%) . The particularly prominent increase in incidence is ptially dependent on the low incidence rates in the early years of the study, however there is no evidence to suggest that ascertainment was especially poor in this early period.
Published scientific and medical literature does not appear to document geographical differences, particuly within a country, in incidence for this group of childhood malignan- (Kuijten & Bunin 1993) reported two studies showing a positive association for parental 'professional occupations' and higher social class, which is consistent with the Scottish findings. Two fuirther studies (Kuijten & Bnin, 1993) and one recent study (McCredie et al., 1994) observed reduced levels of education in the parents of case children. The newly described association with higher social groups found in the present study requires confirmation from other independent data sets. However, the strength of the association means that future statistical analysis of distribution should account for socioeconomic status. The study findings of variation in incidence by both health board area and deprivation category appear to be independent of each other on preliminary examination of the data. Areas with a high proportion of post code sectors in the most affluent Carstairs category are not necesarily those with SRRs greater than 100. Similarly, those with high proportions of post code sectors in the most deprived category (e.g. Greater Glasgow) do not necessarily have low SRRs. The relationship between geographical area and socioeconomic level is currently being investigated.
In conclusion, we have demonstrated a requirement for validation of cancer registry data to be employed in detailed studies of geographical distnbution where few cases can influence results. These types of studies should also consider taling socioeconomic levels into account.
